Presented positive interim data for 4D-150 in wet age-related macular degeneration (wet AMD) from PRISM Phase 1/2 clinical trial highlighting ...

For companies like Tesla and Lamborghini, embracing crypto may open new opportunities and even stabilize stock performance by ...

SOL-1 expected to be fully randomized by YE 2024 with topline data expected in Q4 2025 Active clinical trial sites now enrolling patients d ...

Adidas sale: deals from $5 @ Amazon The Adidas Store at Amazon is offering a wide variety of Black Friday deals on men's/women's/children's sweat pants, hoodies, socks, and more. After discount, deals ...

Advanced Micro Devices is laying off 4% of its global workforce, or about 1,000 employees, as it directs efforts towards ...

AMD has confirmed that it’s laying off 4% of its workforce to focus on “large growth opportunities.” It’s unclear how many ...

NEC revealed the specifics of the supercomputer, which is set to go into operation in July 2025 at the Rokkasho Institute for ...

US chip manufacturer AMD is cutting four percent of its global workforce and focusing on the development of AI chips.

The US is considering expanding its export limits on AI chips to China and its allies. Experts say the race for AI dominance ...

Meanwhile, GSC confirmed Stalker 2 will feature upscaling options for DLSS and FSR. Specifically, Stalker 2 launches with ...

The company’s lead gene therapy product, 4D-150, is showing potential in revolutionizing the treatment for wet AMD with its dual transgene approach, offering comprehensive VEGF inhibition and durable ...